NCT05035654 - LYR-220 for Adult Subjects With Chronic Rhinosinusitis (BEACON Study) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 23, 2021

Primary Completion Date

August 30, 2023

Study Completion Date

August 30, 2023

Conditions

Chronic SinusitisChronic Rhinosinusitis (Diagnosis)

Interventions

DRUG

LYR-220 Design 1 (Part 1 only)

LYR-220 drug matrix (mometasone furoate 7500 µg) Design 1

DRUG

LYR-220 Design 2 (Part 1 and Part 2)

LYR-220 drug matrix (mometasone furoate 7500 µg) Design 2

DRUG

Bilateral sham procedure control (Part 2)

Bilateral sham procedure control

Trial Locations (25)

5042

Lyra Investigational Site, Bedford Park

10016

Lyra Investigational Site, New York

11042

Lyra Investigational Site, New Hyde Park

18017

Lyra Investigational Site, Bethlehem

21204

Lyra Investigational Site, Baltimore

27103

Lyra Investigational Site, Winston-Salem

27599

Lyra Investigational Site, Chapel Hill

29118

Lyra Investigational Site, Orangeburg

29303

Lyra Investigational Site, Spartanburg

40205

Lyra Investigational Site, Louisville

47150

Lyra Investigational Site, New Albany

60208

Lyra Investigational Site, Chicago

60657

Lyra Investigational Site, Chicago

70072

Lyra Investigational Site, Marrero

75069

Lyra Investigational Site, McKinney

76109

Lyra Investigational Site, Fort Worth

78258

Lyra Investigational Site, San Antonio

84405

Lyra Investigational Site, South Ogden

90501

Lyra Investigational Site, Torrance

91942

Lyra Investigational Site, La Mesa

92008

Lyra Investigational Site, Carlsbad

95661

Lyra Investigational Site, Roseville

99201

Lyra Investigational Site, Spokane

Unknown

Lyra Investigational Site, Brisbane

Lyra Investigational Site, Melbourne